Presenter Jane Jeffrie Seley, Program Manager of the Inpatient Glycemic Control Program at NewYork-Presbyterian Hospital/Weill Cornell Medicine, to Focus on Strategies to Engage Nursing Staff in Glycemic Management Practices.

Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today announced that the company will host a complimentary educational webinar, “The Role of Nursing in the Continuum of Inpatient Diabetes Care,” on May 23, from 1-2 p.m. EDT.

During this webinar, Jane Jeffrie Seley, DNP, MSN, MPH, GNP, RN, BC-ADM, CDE, CDTC, FAADE, FAAN, Program Manager of the Inpatient Glycemic Control Program at NewYork-Presbyterian Hospital/Weill Cornell Medicine, will present on the elements of effective glycemic management requiring nursing coordination of care and best practice to engage your nursing staff. Following the presentation, Dr. Seley will be joined by Travis Scott, Nurse Educator at Oregon Health & Science University and Laurel Fuqua, Monarch’s EVP and Chief Clinical Officer, for a panel discussion sharing experiences and successful examples of improving engagement, care coordination, and staff education to optimize diabetes care and improve patient outcomes.

“Nurses spend the most time on direct patient care, and therefore, are well positioned to implement innovative strategies to improve glycemic management in the hospital,” said Dr. Seley. “Nurses should receive ongoing education in how to identify, treat and prevent malgylcemia, individualize discharge planning, and educate and empower patients to perform self-management at home. During this webinar, we will explore the role nurses play and effective strategies to engage nursing staff and optimize inpatient diabetes care.”

For more information and to register for the webinar, visit the Monarch website. The event will be recorded and available for on-demand viewing on the website 24 hours following the live event.

About Monarch Medical Technologies
Monarch Medical Technologies is the leading provider of electronic systems for inpatient glycemic management. Monarch’s EndoTool® Glucose Management System offers personalized dosing recommendations for intravenous and subcutaneous insulin therapy. As a Class II FDA-cleared, patent pending software suite, EndoTool has enabled more than 225 hospitals to provide unsurpassed patient-specific glycemic control across a broad population of patients, and ultimately deliver better, safer care. For more information, please visit monarchmedtech.com.